Recombinant human interferon alpha-1b (Shenzhen Kexing Biotech)

重组人干扰素α-1b（深圳科兴）

Report date: 2024/04/17 10:52:18

Base Information

Drug NameRecombinant human interferon alpha-1b (Shenzhen Kexing Biotech)
Drug Alias NameHuman interferon α1b Inhalation Solution (Shenzhen Kexing Biotech)SINOGEN赛若金
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsLower Respiratory Tract InfectionsNeoplasmsRespiratory Syncytial Virus Infections +[6] 
Global Approved IndicationsNeoplasmsVirus Diseases
Approved Indications in ChinaNeoplasmsVirus Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Kexing Biological Engineering Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Kexing Bio-Products Co LtdShenzhen Kexing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsLower Respiratory Tract InfectionsNeoplasmsRespiratory Syncytial Virus Infections +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB
Related LinksN/A